SOUTH SAN FRANCISCO, Calif. (AP) — MyoKardia Inc. (MYOK) on Thursday reported a fourth-quarter loss of $7.4 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 21 cents.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share.

The biopharmaceutical company posted revenue of $5.6 million in the period.

For the year, the company reported that its loss widened to $46 million, or $1.40 per share. Revenue was reported as $22.5 million.

MyoKardia shares have climbed 31 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $54.95, more than quadrupling in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MYOK at

Automated Insights

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.